secwatch.observer — SEC 8-K summary
======================================

Issuer:     RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK:        0001649904
Form:       8-K
Filed at:   2024-04-01T23:59:59+00:00
Accession:  0001104659-24-041970
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rhythm Pharma raises $150M in convertible preferred stock; conversion at $48 (19% premium)
--------------------------------------------------------------------------------

- $150M gross proceeds from sale of Series A Convertible Preferred Stock to Perceptive and other existing shareholders.
- Initial conversion price of $48 per share, representing a 19% premium to the 10-day VWAP.
- Cash runway extended into 2026; includes existing cash and net proceeds from the offering.
- Preferred stock pays 6% cumulative annual dividend starting year 2, payable PIK or cash at company's option.
- Convertible after HSR waiting period; company can force conversion if stock >250% of conversion price for 20 of 30 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649904/000110465924041970/0001104659-24-041970-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649904/000110465924041970/tm2410287d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-041970

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer